Immunomodulatory therapy in refractory/recurrent ovarian cancer

Immunomodulatory therapy in refractory/recurrent ovarian cancer

Objective: To investigate the efficacy and toxicity of immunomodulatory therapy (IMT) alone or as an add-on to palliative/salvage chemotherapy in patients with refractory/recurrent epithelial ovarian cancer (EOC). Materials and methods: We retrospectively analyzed the efficacy and toxicity of IMT in...

Full description

Bibliographic Details
Main Authors: Chao-Yu Chen, Chyong-Huey Lai, Lan-Yan Yang, Yun-Hsin Tang, Hung-Hsueh Chou, Chee-Jen Chang, Cheng-Tao Lin
Format: Article
Language:English
Published: Elsevier 2015-04-01
Series:Taiwanese Journal of Obstetrics & Gynecology
Subjects:
epithelial ovarian cancer
immunomodulatory therapy
recurrence
Online Access:http://www.sciencedirect.com/science/article/pii/S1028455915000273

Internet

http://www.sciencedirect.com/science/article/pii/S1028455915000273

Similar Items